Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis-Reference-Cited by-同舟云学术

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

Published:2020-08-01 Issue:8 Volume:156 Page:863
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Silverberg Jonathan I.¹,Simpson Eric L.²,Thyssen Jacob P.³,Gooderham Melinda⁴,Chan Gary⁵,Feeney Claire⁶,Biswas Pinaki⁷,Valdez Hernan⁷,DiBonaventura Marco⁷,Nduaka Chudy⁸,Rojo Ricardo⁵

Affiliation:

1. Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC

2. Department of Dermatology, Oregon Health & Science University, Portland

3. Department of Dermatology and Allergy, Herlev-Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

4. SKiN Centre for Dermatology, Queen’s University and Probity Medical Research, Peterborough, Ontario, Canada

5. Pfizer Inc, Groton, Connecticut

6. Pfizer Ltd, Surrey, United Kingdom

7. Pfizer Inc, New York, New York

8. Pfizer Inc, Collegeville, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2766772/jamadermatology_silverberg_2020_oi_200027.pdf

Reference36 articles.

1. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.;Suárez-Fariñas;J Allergy Clin Immunol,2011

2. Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape.;Boguniewicz;Ann Allergy Asthma Immunol,2018

3. Pain is a common and burdensome symptom of atopic dermatitis in United States adults.;Silverberg;J Allergy Clin Immunol Pract,2019

4. Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis.;Newton;J Patient Rep Outcomes,2019

5. Burden of skin pain in atopic dermatitis.;Vakharia;Ann Allergy Asthma Immunol,2017

Cited by 285 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitor selectivity: new opportunities, better drugs?;Nature Reviews Rheumatology;2024-09-09

2. A γδ T cell–IL-3 axis controls allergic responses through sensory neurons;Nature;2024-09-04

3. Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis;Journal of Dermatological Treatment;2024-09

4. Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates;Dermatology and Therapy;2024-08-22

5. Biologic and Small Molecule Therapy in Atopic Dermatitis;Biomedicines;2024-08-13